Mental Images in Nonsuicidal Self-Injury Disorder (NSSID)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00011854

Enrollment

Registered

2017-10-25

Start date

2017-03-21

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-suicidal self-injury disorder

Interventions

Group 1: Part 1: Female University students who have frequently engaged in NSSI are asked in an online questionnaire whether they have also experienced any mental images on NSSI. They are informed abo

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Part 1 (online survey): female student who have at least five times engaged in NSSI over the past year; Part 2 (interview and daily diary): female student, NSSID-criteria, at least once engaged in NSSI during the week before the online-survey, experience of mental imagery on NSSI

Exclusion criteria

Exclusion criteria: Part 1: There are no exclusion criteria due to self-administration into the online study. Part 2: acute suicidality or extinction, schizophrenia or related illnesses, substance addiction (including alcohol)

Design outcomes

Primary

Measure	Time frame
Part 1: The experience of mental images is assessed with one item (yes/no). Part 2: The frequency of NSSI is assessed at baseline with the DSHI and the BSL-95. The frequency of NSSI is further observed with the Diary. The frequency of mental images on NSSI is asked upon at baseline regarding the week prior to assessment. It is further observed with the diary. The affect that was present after the mental image is measured at baseline and daily with the positive and negative affective state (PANAS). Certain characteristics of mental images such as vividness, compellingness, controllability, nowness, distress, and soothingness are measured with one items each (scale 1-9). Other features such as content or associated cognitions are assessed with an open-ended question. All imagery features are assessed both at baseline and daily. The feeling of entrapment is measured at baseline with the Entrapment Scale, and with one item daily (scale 1-9), along with the feeling of defeat with one item daily (scale 1-9).	—

Measure

Time frame

Part 1: The experience of mental images is assessed with one item (yes/no). Part 2: The frequency of NSSI is assessed at baseline with the DSHI and the BSL-95. The frequency of NSSI is further observed with the Diary. The frequency of mental images on NSSI is asked upon at baseline regarding the week prior to assessment. It is further observed with the diary. The affect that was present after the mental image is measured at baseline and daily with the positive and negative affective state (PANAS). Certain characteristics of mental images such as vividness, compellingness, controllability, nowness, distress, and soothingness are measured with one items each (scale 1-9). Other features such as content or associated cognitions are assessed with an open-ended question. All imagery features are assessed both at baseline and daily. The feeling of entrapment is measured at baseline with the Entrapment Scale, and with one item daily (scale 1-9), along with the feeling of defeat with one item daily (scale 1-9).

—

Secondary

Measure	Time frame
All secondary outcomes are measured at baseline only. The attitude towards NSSI is measured with one item (scale 1-9). Further outcomes are (questionnaire in parentheses): Imagery vividness (QMI) and intrusiveness (IVIQ), general psychopatholgy (SCL-27), anxiety and depression (DASS), Borderline symptoms (BSL-23), compulsiveness (OCI-R), impulsivity (UPPS) and the impact of future events (IFES).	—

Countries

Germany

Contacts

Public ContactMarie Cloos

Abteilung für Klinische Psychologie und Psychotherapie des psychologischen Instituts der J.W. Goethe-Universität Frankfurt

cloos@psych.uni-frankfurt.de069-79823994

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 28, 2026